share (Baht/Share) 0.21 0.22 (0.01) (5.1) 0.28 0.26 0.02 7.8 In the year 2019, The total revenue from the Company and its subsidiary was Baht 1,648 million which increased from the previous year Baht 37
Cost Q3/2017, the Company and its subsidiaries have the loan interest 21 MB increased from year 2016 in the amount of 2 MB which is the result of the Company more maintain foreign currency in FCD account
21 MB increased from year 2016 in the amount of 2 MB which is the result of the Company more maintain foreign currency in FCD account and manage the capital circulation in short-term liquidity
before interest and tax decreased by Baht 87.91 million whereas corporate tax decreased by 18.56 million, financial cost slightly increased by Baht 0.72 million and profit sharing to minority shareholders
conducted transparently and legitimately by mainly taking into account the benefits of the nation. In this regard, EXAT and the Company/the subsidiary have reached a mutual agreement to settle the disputes in
of the end of Q3/2017 market value of LAC shares increased, resulting in a profit from the mark to market value increment of asset available for sale of THB 1,632 million, which was recorded in other
the follow main reasons. 1. Revenue from hospital operations increased by Baht 102.22 million or 4.52 % due to in 2018 the general patients of Company and subsidiaries increased. 2. Cost of hospital
. Page 3 of 11 Expenses Selling and distribution expenses In Q3/2019, selling and distribution expenses was slightly increased at Baht 0.4 million from same quarter last year but recorded a decrease of
of Shareholders No.1/2019 On March 18, 2019, the Extraordinary General Meeting of Shareholders approved the Company and the subsidiary to settle the disputes with the Expressway Authority of Thailand